Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . September 30th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis B - Falling alpha-fetoprotein suggests poor outcomes in severe acute hepatitis
Hepatitis C Screening - Untranslated virus region ineffective for distinguishing hepatitis C subtypes
Blood Testing - Molecular HIV/HCV screen fast, accurate
Fatty Liver - Japanese study lists factors marking steatohepatitis
Hepatitis B Virus - Viral DNA, end-stage liver disease heighten risk for drug-resistant mutants
AIDS Therapies - Triangle announces reacquisition of product rights from Abbott
Finance - Second quarter 2002 revenues increase 12.3% says molecular diagnostics firm
Legal Issues - Ribapharm sues Hoffmann-La Roche for hepatitis drug patent
Patents - Additional patent issued for PADRE technology
Patents - Key ruling issued on European vaccine microsphere patent
Restructuring - RPI realigns and restructures; reports Q2 results
Thalassemia - No link between deferiprone and liver fibrosis in transfused patients
Transplant Medicine - Artificial liver trials show progress, as transplant candidates wait
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
